Towards Healthcare Research & Consulting

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Roche's Phase 2 results made a worthy contribution in CT-388
30 January 2026

Roche's Phase 2 results made a worthy contribution in CT-388

Introduction Roche Company is a diagnostics and pharmaceuticals champion straight from the Swiss land. The company has marked its position in the healthcare sector for its personalised solutions, mainly in the oncology field. A huge biotech company, Roche, is known for merging diagnostic tools and ...

Merz's confident submission to EMA
29 January 2026

Merz's confident submission to EMA

Introduction Merz Therapeutics is a family renowned specialty pharmaceutical company smartly developing and introducing effective therapies for movement disorders, liver disease and neurological conditions. Since 2020, the company has been travelling across 90 countries with its expert-level perfor...

L7 Informatics expectations from AI
29 January 2026

L7 Informatics expectations from AI

Introduction L7 Informatics is a multi-tasking, responsible company that serves the L7/ESP® Enterprise Science Platform to discard data pits in the biotech, healthcare and life sciences industry. The company is famous for its excellent role in the biotech firms, diagnostic labs, academic resear...

Parkinson's Promising Therapies
29 January 2026

Parkinson's Promising Therapies

Introduction Parkinson’s disease (PD), a neurological disorder, takes place due to the brain’s low capacity to generate required dopamine, showing symptoms such as slowness, plus non-motor problems, tremors, etc., that later lead to fatigue, depression and sleep issues. The treatment to...

Corcept's Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy
29 January 2026

Corcept's Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy

Introduction Corcept Therapeutics, a popular commercial-driven pharmaceutical company known for its main cortisol modulators, heals extreme oncologic, neurological, metabolic, and endocrinologic conditions. The company strongly prioritises technology, as cortisol activity is a core responsibility f...

Insilico builds a home for AI models
28 January 2026

Insilico builds a home for AI models

Introduction Insilico Medicine, a famous biotechnology company, is known for its excellence in generative AI. Since 2014, the company has boosted the drug discovery and establishment to the core with its brilliance and dedication. The evergreen AI technology introduced waves of opportunities to man...

Myllia's Echoes of Silenced Genes: positive noise in CRISPR perturbation
28 January 2026

Myllia's Echoes of Silenced Genes: positive noise in CRISPR perturbation

Introduction Myllia Biotechnology is a champion in merging bandwidth, CRISPR screening, and single-cell RNA sequencing. The company is popular as ‘Aelian Biotechnology’ along with its advanced genetic perturbation usage in specifically cancer and human cells. The company’s sequenc...

Lexicon's 'Get set go' attitude after entering Phase 3
28 January 2026

Lexicon's 'Get set go' attitude after entering Phase 3

Introduction Lexicon Pharmaceuticals entered the competition in 1995 with its excellent small molecule drugs harnessed with gene knockout technology. The main target of the company is chronic issues in oncology, neurology and cardiometabolism. Its popular products like LX9211 and INPEFA are a boon ...

BMS, along with Janux, is ready to upgrade cancer drugs
28 January 2026

BMS, along with Janux, is ready to upgrade cancer drugs

Introduction Bristol Myers Squibb (BMS), a leading biopharmaceutical company, aims to address immunology, cardiovascular, haematology, and oncology with its innovative and effective medicines, backed by a smart approach to discovering, establishing, and delivering excellence in these complex condit...

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia
27 January 2026

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia

Introduction IntraBio Inc. operates in the healthy air of Austin, Texas, with its innovative treatment development for common and rare neurodegenerative conditions. The company sharpens its smartness from Munich and the University of Oxford with its delivery of essential products to the calcium bui...